Role of estrogen in pulmonary lymphangioleiomyomatosis

Jian Wang,Ling Ye,Yan Mou,Meiling Jin
DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2014.22.014
2014-01-01
Abstract:Pulmonary lymphangioleiomyomatosis (PLAM) is a rare disease which presents the diffuse progressive destruction to the pulmonary parenchyma.None effective treatments are currently proposed for this disease.PLAM occurs almost exclusively in women in the childbearing years,so it indicates that the disease is closely associated with estrogen.As the mechanism of the function of estrogen in PLAM has not been clarified entirely,the latest studies will be reviewed to increase the awareness to the effect of estrogen on PLAM and to advance the development of new therapeutic strategies.
What problem does this paper attempt to address?